Literature DB >> 8405962

Outer membrane complex proteins of Chlamydia pneumoniae.

M P Melgosa1, C C Kuo, L A Campbell.   

Abstract

The protein composition of the outer membrane complex (OMC) of Chlamydia pneumoniae strain AR-39 was analyzed by metabolic labeling with [35S]methionine and [35S]cysteine. Cysteine-rich proteins with molecular masses of 98, 60 doublet, 39.5 (MOMP) and 15.5 kDa were found in the OMC of C. pneumoniae. The cysteine-rich proteins of the OMCs of the three Chlamydia species showed specific reaction patterns by immunoassay and autoradiography to rabbit or turkey immune sera. Recognition of the MOMP and 60-kDa proteins of the three species was cross-reactive. However, the C. pneumoniae 98-kDa protein was recognized by anti-C. pneumoniae (AR-39) and anti-C. psittaci (TT3) immune sera. None of the immune sera recognized the 12-kDa cysteine-rich complex.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8405962     DOI： 10.1111/j.1574-6968.1993.tb06448.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN： 0378-1097            Impact factor:   2.742


  19 in total

1.  Labsystems enzyme immunoassay for Chlamydia pneumoniae also detects Chlamydia psittaci infections.

Authors:  K Strålin; H Fredlund; P Olcén
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

2.  A Chlamydia trachomatis OmcB C-terminal fragment is released into the host cell cytoplasm and is immunogenic in humans.

Authors:  Manli Qi; Siqi Gong; Lei Lei; Quanzhong Liu; Guangming Zhong
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

3.  Identification of two novel genes encoding 97- to 99-kilodalton outer membrane proteins of Chlamydia pneumoniae.

Authors:  K Knudsen; A S Madsen; P Mygind; G Christiansen; S Birkelund
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 4.  Polarity and the diversity of growth mechanisms in bacteria.

Authors:  Pamela J B Brown; David T Kysela; Yves V Brun
Journal:  Semin Cell Dev Biol       Date:  2011-06-29       Impact factor: 7.727

5.  Analysis of the humoral immune response to Chlamydia pneumoniae by immunoblotting and immunoprecipitation.

Authors:  A Essig; U Simnacher; M Susa; R Marre
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

6.  Chlamydia pneumoniae uses the mannose 6-phosphate/insulin-like growth factor 2 receptor for infection of endothelial cells.

Authors:  Mirja Puolakkainen; Cho-Chou Kuo; Lee Ann Campbell
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 7.  Disulfide cross-linked envelope proteins: the functional equivalent of peptidoglycan in chlamydiae?

Authors:  T P Hatch
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

8.  Production of Chlamydia pneumoniae proteins in Bacillus subtilis and their use in characterizing immune responses in the experimental infection model.

Authors:  Ulla Airaksinen; Tuula Penttilä; Eva Wahlström; Jenni M Vuola; Mirja Puolakkainen; Matti Sarvas
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

9.  Detection of Chlamydia pneumoniae-specific antibodies binding to the VD2 and VD3 regions of the major outer membrane protein.

Authors:  Marcus Klein; Arne Kötz; Katussevani Bernardo; Martin Krönke
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

10.  Retinoic acid inhibits the infectivity and growth of Chlamydia pneumoniae in epithelial and endothelial cells through different receptors.

Authors:  Mirja Puolakkainen; Amy Lee; Tadayoshi Nosaka; Hideto Fukushi; Cho-Chou Kuo; Lee Ann Campbell
Journal:  Microb Pathog       Date:  2007-11-23       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.